sign in sign up
<<
Home , Metadoxine

Page 1 of 29

Tender for Testing of Drugs for The Year 2013-2015

CENTRAL STORES DIRECTORATE (MEDICAL) DELHI ESI DISPENSARY COMPLEX TILAK VIHAR, NEW DELHI-110018 Phone No.28335358 & 28335360, Fax 28335357 www.esic.nic.in & www.dmdesic.nic.in

DMU-16/55/RC/Testing of drugs/2013/CS Dated ………2013

Subject: Invitation of tender and Instructions to Tenderers.

Note: The envelope containing the tender as well as subsequent Communications should be addressed and delivered to:

The Director (Medical) Delhi, E.S.I. Dispensary Complex Tilak Vihar,New Delhi- 110018.

All communications must be addressed to the officer named above by title only and not by name.

From :

The Director (Medical) Delhi ESI Dispensary Complex Tilak Vihar,New Delhi-110018. To

M/s. ______

______

Dear Sir/Madam

I invite the tender for the testing of Drugs as per the items detailed in schedule attached. The conditions of the contract which will govern any contract made are given here under and in the general conditions of the contract (Annexure – I) and special instructions (Annexure – II) attached to this tender invitation. If you are in a position to quote for testing of drugs in accordance with the requirements stated in the attached schedule. Please submit your quotation to this office.

1. SIGNING OF TENDER Individuals signing tender or other documents connected with the contract specify:- (i) Whether signing as a "Sole Proprietor" of the firm or his attorney. Page 2 of 29

(ii) Whether signing as a "Registered Active Partner" of the firm or his attorney. (iii) Whether signing for the firm "Per Procurationem." (iv) In the case of companies and firms registered under the Indian Partnership Act the capacity in which signing, e.g.Secretary, Manager, Partner etc. or their attorney and produce copy of document, empowering him to do so, if called upon to do so. Note: In case of unregistered firms all the members or all attorneys duly authorised by all of them or the Manager of the firm should sign the tender and subsequent documents.

2. PERIOD FOR WHICH THE OFFER WILL REMAIN OPEN

The quotation shall remain open for a period of one year from the date of opening of tender.

3. Director (Medical) Delhi/Medical Superintendent, ESI Hospital New Delhi does not pledge himself to accept the lowest or any tender and reserves the right of accepting the whole or any part of the tender. after complete formalities required for the formal acceptance of the tender and will be forwarded to the tenderer as soon as possible and the instruction contained in the communication should be acted upon immediately.

Acceptance of tender by competent authority will be communicated by a letter of acceptance after completion of formalities required for the formal acceptance of the tender and will be forwarded to the tenderer as soon as possible and the instruction contained in the communication should be acted upon immediately.

Yours faithfully,

Director (Medical) Delhi/Medical Superintendent ESI Corporation

Page 3 of 29

ANNEXURE-I

GENERAL CONDITION CONTRACT

1. DEFINITIONS:

In the interpretation of the contract and the general and /or special condition governing it, unless the context otherwise requires:-

(a) The term 'Contract shall mean the invitation to tender, the instructions to tenderer acceptance of the tender schedule, particulars" hereinafter defined and those general and special conditions that may be added.

(b) The term "Contractor" shall mean the person, firm or Company with whom the order for drug testing is placed and shall deem to include the contractor's successor (approved by the purchaser) representatives, heirs, executors and administrators unless excluded by the contract.

(c) 'Contract price' shall mean the price of tests accepted or the prices calculated in accordance with the prices accepted by or on behalf or of the purchaser.

(d) The term "delivery" shall mean delivery of reports by the dates specified in the acceptance of tender of drug testing

(e) The term "Corporation" shall means the Employees"State Insurance Corporation.

(f) The term Director (Medical)Delhi/Medical Superintendent, ESI Hospital and any other officer authorised for the time being in the administration of ESI Corporation and any other officer authorised for the time being to execute contract relating to the drug testing on behalf of the purchaser.

(g) The term “Purchaser” shall mean purchaser or purchasers named in the schedule to tender, his or their successors or assignees.

(h) The term "test" shall mean such test or tests as are prescribed by the specification or considered necessary by the purchaser.

2. Authority of person signing document:

A person signing the tender Form or any documents forming part of the contract on behalf of another shall be deemed to warranty, that he has authority to bind such other and if, on enquiry, it appears that the person so, signing had no authority to do so, the Director (Medical)Delhi/Medical Superintendent, ESI Hospital may without prejudice to other Civil and criminal remedies Page 4 of 29

cancel contract and held the signatory liable for all cost and damages.

3. RESPONSIBILITY FOR EXECUTING CONTRACT

The Contractor is to be entirely responsible for the execution of the contract in all respects in accordance with the Terms and conditions as specified in the acceptance of tender and the schedule annexed there-to.

4. SUBLETTING OF CONTRACT:

The Contractor shall not sublet, transfer or assign the contract or any part thereof without the written permission of the Director (Medical)Delhi/Medical Superintendent. In the event of the contractor contravening this condition the Director (Medical)Delhi/Medical Superintendent, be entitled to place the contract elsewhere on the contractors account at his risk and the contractor shall be liable for any loss or damage with the Director (Medical)Delhi/Medical Superintendent ESI Hospital, may sustain in consequence of arising out of such replacing of the contract.

5. EARNEST MONEY:

The tenderer shall have to deposit Earnest Money Rs. 5000.00 as per terms and condition of tender In the event of withdrawal/revocation of tender before the date specified for acceptance, the Earnest Money shall stand forfeited.

6. SECURITY DEPOSIT:

In case selected, EMD will be kept as security deposit.

Performance security is required to protect the purchaser against the risk of the contractor’s conduct which would warrant the forfeiture of the performance security. Performance security of the contractor will be forfeited, if the contractor withdraws or amends without prior consent or impairs or derogates from the tender in any respect with the period validity of rate contract or if it comes to notice that information documents furnished is incorrect, false, misleading or forged without prejudice to other right of the purchaser. The performance security will also be forfeited without prejudice to other right of the purchaser if it fails to furnish the required performance with in the specified period (validity period).

7. Recovery of sums due: Whenever any claim for the payment of a sum of money arises out of or under this contract against the contractor the purchaser shall be entitled to recover of such sum by appropriating, in part or whole the security/earnest money deposited by the contractor, if a security/earnest money is taken against the contract. In the event of the security/earnest money Page 5 of 29

being insufficient or if no security/earnest money has been deposited by the contractor, then the balance or the total sum to be recoverable, as the case may be shall be deducted from any sum then due or which at any time thereafter may become due to contractor under this or any other contract with the purchaser. Should this sum not be sufficient to cover the full amount recoverable, the contractor shall pay to the purchaser on demand the remaining balance due.

8. Insolvency and Breach of Contract:

The Director (Medical) Delhi/Medical Superintendent may at any time by notice in writing summarily terminate the contract without compensation to the contractor in any of the following contingencies, that is to say:-

(i) If the contractor being an individual or if firm, any partner in the contractor's firm, shall at any time be adjudged insolvent or shall have a receiving order or orders for administration of his estate made against him or shall take any proceedings for liquidation or composition under any insolvency Act for the time being in force or shall make any conveyance or assignment of this effects or enter into any arrangements or composition with his creditors or suspend payment or if the firm be dissolved under Partnership Act, or

(ii) If the contractor being a company shall pass a resolution or the courts shall make an order for the liquidation of the affairs or a receiver or Manager on behalf of the debenture holder shall be appointed or circumstances shall have arisen whichentitled the court or debenture holders to appoint a receiver or Manager, or

(iii) If the contractor commits any breach of this contract not herein specifically provided for:

Provided always that such determination shall not prejudice any right of action or remedy which shall have accrued or shall accrue thereafter to the purchaser and provided also that the contractor shall be liable to pay the purchaser for any extra expenditure he is thereby put to but shall not be entitled to any gain on repurchased.

9. Arbitration :-

In the event of any question, dispute or difference arising under these conditions or any special conditions of contract, or in connection with this contract, except as to nay matter the decision of which is specially provided for by these on Page 6 of 29

the special conditions the same shall be referred to the sole arbitration of the Director (Medical )Delhi/Medical Superintendent or some other person appointed by him. It will be no objection that the arbitrator is a Government servant, that he had to deal with the matter to which the contract relates for that is the course of his duties as a Government Servant he had expressed views on all or any of the arbitration dispute or difference. The award of the arbitrator shall be final and binding on the parties to the contract.

It is a term of the contract:- (a) If the arbitrator be the Director(Medical)Delhi/Medical Superintendent ESI scheme: (i) In the event of his being transferred or vacating his office by resignation or otherwise, it shall be lawful or his successor in-office either to proceed with the reference himself or to appoint another person as arbitrator: or

(ii) In the event of his becoming unable to act, for any reason it shall be lawful for Director (Medical)Delhi/Medical Superintendent to appoint another person as arbitrator.

(b) If the arbitrator be a person appointed by the Director (Medical) Delhi/Medical Superintendent

In the event of his dying, neglecting or refusing to act, being unable to act, for any reasons in shall be lawful for the Director (Medical )Delhi/Medical Superintendent either to proceedwith the reference himself or to appoint another person as arbitrator in place of the outgoing arbitrator.

It is further a term of this contract that no person other than the Director General, Employees" State Insurance Corporation or the person appointed by him should act as arbitrator and that, if for any reason that is not possible, the matter is not to be referred to arbitrator at all.

Upon every and such reference, the assessment of the costs incidental to the reference and award respectively shall be in the discretion of the arbitrator.

Subject as aforesaid the Arbitrator Act, 1940 and the rules there under and any statutory modifications thereof for the time being in force shall be deemed to apply to the arbitrator proceedings under this clause.

Work under the contract shall, if reasonable possible continue during the arbitration proceeding and no payment due to Page 7 of 29

payable by the purchaser shall be withheld on account of proceedings:- The venue of arbitration shall be Delhi. In this clause the expression," the Director General, Employees' State Insurance Corporation” means the Director (Medical) Delhi/Medical Superintendent ESI Scheme for the time being and includes, is there be no Director (Medical )Delhi/Medical Superintendent, the officer who is for the time being the administrative head of the Employees' State Insurance Corporation, whether in addition or otherwise.

For the purpose of the contract including arbitrator proceedings there under, the Director(Medical)Delhi/ Medical Superintendent ESI Hospital shall be entitled to exercise all the rights and Powers of the purchaser.

Fraud & Corruption

The bidder, supplier, contractor and the consultants observe the highest standard of ethics during the procurement & execution of such contracts in pursuit of this:

a) Defines, for the purposes of this provision, the terms set forth below as follow:- i. “Corrupt Practice” means the offering, giving, receiving or soliciting directly or indirectly of anything of value to influence the action of public official in the procurement process or in contract execution. ii. “Fraudulent Practice” means a misrepresentation or omission of facts in order to influence a procurement process or the execution of a contract. iii. “Collusive Practice” means a scheme or arrangement between two or more bidders, with or without the knowledge of the borrower, designed to establish bid prices at artificial, non competitive levels; and iv. “Coercive Practices” means harming or threatening to harm, directly or indirectly, person or their property to influence their participation in the procurement process or affix to execution of a contract. b) Will reject a proposal for award if it determines that the bidder recommended for award has, directly or through an agent, engaged in corrupt, fraudulent, collusive, coercive practices in competing for the contract in question.

Page 8 of 29

ANNEXURE -II

To the Tender invitation ______SPECIAL INSTRUCTIONS

1. Tenderers are requested to submit their quotations on fixed price basis. 2. Price quoted should be inclusive of testing charges, collection of samples as well as delivery of reports F.O.R. destination in Indian Currency. Tenders not complete in this respect are liable to be ignored.

3. The contractor shall, wherever, called upon to do so give full information with reference to govt. institutions to which services are rendered and shall also permit the Director (Medical )Delhi/ Medical superintendent or any other officer nominated by him to inspect the premises of the tenderer at all reasonable times and shall give all assistance and information as may be required by him in connection with the contract.

JURISDICTION

4. All questions, disputes or difference arising under or out of or in connection with the contract, if included shall be settled by sole Arbitration of Director (Medical)Delhi, Employees State Insurance Scheme or a person appointed by him in this behalf .

INSPECTION AUTHORITY

5. The Director (Medial) Delhi or the Agent/Inspector nominated by him shall be the inspecting authority.

6. It may be noted that the unsuccessful tenderer will not be informed about the result of his tender.

Page 9 of 29

Annexure-III

Forwarding letter of the firm (On Firm’s Letter Head)

From

______

______

______

To Director (Medical) Delhi, Directorate (Medical) Delhi, ESI Dispensary Complex, Tilak Vihar, New Delhi-110018

Sub: Testing of drugs at the quoted rate to Director (Medical) Delhi, for the period of Two years i.e. 2013-2015

Sir,

M/s. I/We/am/are authorized signatories of

I/ we hereby undertake as follows:-

1. I/we hereby undertake to do testing of drugs mentioned in Annuxure ‘A’ in areas specified by the Director (Medical) Delhi, ESI Dispensary Complex, Tilak Vihar for the period of Two years at the rates quoted by me/us in the prescribed tender form, which is submitted herewith according to the instructions and the terms and conditions. The duration of the said contract may be extended on the same terms and conditions & rates if the Director(Medical)Delhi so desires.

2. The rates quoted against each testing items by me/us in the tender are inclusive of all service charges, transportation charges and duties/taxes payable during the contract period.

3. Necessary documents as required are enclosed herewith in the order in which they are mentioned.

4. I/we understand that security deposit submitted on entering into contract, is likely to be forfeited in the event of lapse on my/our part to comply with the terms and conditions of the tender if proven to have followed unscrupulous practices apart from the liability of penal action for violating the law of the land. Page 10 of 29

5. I/we have carefully read and understood the terms and conditions to avoid any error, omission. I/we shall abide by these conditions. I/we will follow them very scrupulously.

6. My/our firm has not been blacklisted by any other Govt. institution/ Organisation during the last three years.

7. I/we also take cognizance of the fact that failure to furnish the information called for by the Director(Medical) Delhi or to comply with any requirements laid down under the conditions will be considered as disqualification and the tender by rejection on that account

8. I/we undertake to abide by the instructions issued by the Director (Medical) Delhi from time to time.

9. In case of my report declared wrong by any Govt./Govt. approved agency I/we am/are liable for appropriate action.

10. The rate quoted by me/us will not be higher than the rate quoted by me/us to any Govt. Institution/agency with in Govt. of NCT of Delhi/Noida region during the contract period.

I/we hereby undertake to abide by the terms and conditions of the contract modified from time to time and I/we have signed all the papers of terms and conditions and filled up prescribed Performas given along with the tender.

Yours faithfully,

(Signature of tenderer with stamp) (Authorized Signatory)

Page 11 of 29

Annexure-IV

CENTRAL STORES DIRECTORATE (MEDICAL) DELHI ESI SCHEME: ESI DISPENSARY COMPLEX: TILAK VIHAR: NEW DELHI-110018

INSTRUCTIONS SUPPLEMENT/ TERMS AND CONDITIONS FOR RATE CONTRACT of TESTING OF DRUGS (2013-2015) Sub: Tender Enquiry-Rate Contract for Testing of Drugs for ESI Scheme in Delhi & NOIDA.

1.Sealed Tenders are invited in single bid system on behalf of Director (Medical)Delhi,ESI Corporation for the formation of Rate Contract for two years (2013- 15) from Govt.approved firms for testing of drugs as per specification detailed in (Annexure-A). 2.Tender document can be obtained from the office of Dy. Manager(Stores), Central Store, ESI Dispensary Complex, Tilak Vihar, New Delhi-110018 on any working day between 10.00AM to 1.00 PM up to 09.01.2014. Against the payment of Rs.200/- (Rs.Two Hundred Only Non-refundable) in the form of Demand Draft/Bankers Cheque in favour of ESIC Fund Account No.1 Payable at New Delhi.

3. Tender document can be downloaded from ESIC Website www. esic.nic.in & www.dmdesic.nic.in 4. Those who are downloading the tender document from website should submit Rs 200/-(RS. Two Hundred Only Non-refundable)as Tender Cost in the form of Demand Draft/Bankers Cheque in favour of ESIC Fund Account No.1 Payable at New Delhi along with tender documents.

5. Sealed Tender Form (Covering Enevelope)complete in all respect signed with stamp of the firm on each page should be dropped in the Tender Box kept in chamber of Dy.Manager(Stores) at Central Stores upto 1.00P.M. on 09.01.2014.The tender will be opened at 2.30PM on 09.01.2014(the same day) .If 09.01.2014 is declared a holiday,tender will be opened on the next working day at same time. Tender received late will not be entertained. Tenderer/Representative may attend the tender opening process.

6. Earnest Money of Rs.5000/-(Five thousands only)is to be deposited either through Banker's cheque or Demand Draft in favour of "ESIC fund Account No.1".The EMD deposited with earlier tenders will not be adjusted against this tender. Tenders without EMD will not be entertained Page 12 of 29

7. The Rate Contract will be valid for Two years from the date of finalisation of the tender. The duration of said contract may be extended on the same terms and conditions and rates if Director (Medical) Delhi so desires .

8. Samples of Drug testing shall be given to the selected tenderers on rotation and if samples are not collected by the assigned tenderer on the day allotted,sample will be given to next tenderer or in rotation. 9. Samples must be collected from central store, ESI Dispensary Complex, Tilak Vihar, New Delhi 110018 at least once a week or as desired by purchaser at cost and risk of the firm.

10. Reports must be submitted within the period as specified by the laboratory. The cut off date of submission of report shall be from the 3rd day (third day) of actual submission of report. For non submission of reports of the drug testing on time, the tenderer shall be liable to pay 5% (Five percent) of the value of test as penalty per week up to a maximum of 10% (ten percent). if the REPORT of sample collected is not submitted even after two weeks then the items will be tested from next higher bidder and the difference will be recovered from subsequent bills/security money deposit. The cut off date of delivery of report shall be counted from the date of actual dispatch of samples given to representative of laboratory. The extra expenditure involved in testing of drugs will be recovered in full from the firm at the discretion of the competent authority. The risk purchase so imposed will be payable by the firm or will be deducted from the incoming bill(s)/ security money of the firm.

11. List of govt. institutes to be provided for which such services are provided by testing laboratory.

12. An undertaking that the testing charges are not more than the rates charged from other institutions.

13. Copy of valid license for carrying out testing of drugs from appropriate authority.

14. Testing charges are to be mentioned inclusive of all taxes including service charges/Transportation charges in numerical & words. 15. The rates should be applicable for ESI Scheme Delhi & Noida. 16. Payment shall be made within a month after submission of reports & bills.

Page 13 of 29

17. Copy of valid documents in support of registration of VAT/Service Tax and PAN.

18. Tenderer must quote the rates strictly as per the given Format (Hard Copy). Table-I

S. Name of the Quantity of Time required for Rate per Rate per test No. Items drugs delivery of reports test ( in (in words) required for figure) testing 19. Tenderer must submit a copy of quoted rates in CD in Excel Format. 20. Each page of the tender form should be numbered. All the papers in tender form must be completely signed and stamped along with terms and conditions.

21. Tender should be typed. The rates should be quoted in figures as well as in words without any overwriting/cutting/ erasing.IN CASE THERE IS ANY OVERWRITTING /ERASING/CUTTING AND ANY DISCREPENCY IN RATES IN WORDS AND FIGURES THE ITEM WILL NOT BE CONSIDERED. 22. Telegraphic/telex/fax/email/conditional/incomplete tenders will not be entertained and shall be rejected out rightly.

23. Tenderer must quote the rates strictly as per our list of items attached with the tender form mentioning the serial no. of item.

24. The tenderer should also submit an undertaking that all the Terms & Conditions of the Tender are acceptable in complete.

25. Tenderer must be in business for three years w.e.f 2010 in this business which should be supported by undertaking on the Firm’s Letter Head as per enclosed format i.e. Annexure-V.

26. The tenderer should also submit an undertaking that the quoted items have not been & are not being tested for any other organisation at rates lower than being quoted here.

27. The tenderer should submit an Undertaking that the firm is not blacklisted in any Govt. Organisation/Institution.

28. Security Deposit: In case selected, EMD will be kept as security deposit. 29. EMD of unsuccessful tenderer will be returned without any interest within one month after the award of contract. The tenderer should enclose a pre-receipt to this Page 14 of 29

as per Annexure "B". 30. Security of successful tenderer will be returned without any interest on receipt of satisfactory performance report from user departments after the expiry of rate contract.

31. a) Withdrawal of tenders’ along with the earnest money will be allowed before the opening of tender.

After opening of tender:- I) Withdrawal of the complete tender can be allowed but in such cases, the earnest money will be forfeited. II) No change / alteration in rate or other terms in the tender will be permitted under any circumstances. III) Partial withdrawal (in respect of one or more items quoted) will not be allowed under any circumstances. b) There will be no correspondence between the tenderer and the DIRECTOR (MEDICAL) DELHI till the tender is finalized.

32. Samples will be given to tenderer/authorized representatives and reports will be accepted accordingly.

33. All the disputes relating to this tender inquiry and Rate Contract shall be subject to the territorial jurisdiction of courts at Delhi/New Delhi only.

34. The DIRECTOR (MEDICAL) DELHI reserves the right to accept or reject any or all the tenders without assigning any reason (s) thereof and have the right to place order on one or more firms.

35. The tender will be rejected if:- a) Conditional Tender is submitted. b) All the papers are not complete. c) Tender is not sealed properly.

36. The Item quoted will be rejected if:- a) More than one type of rates is quoted for one product. b) The rates quoted are not found same both in figures and words. DATES:-

- LAST DATE OF SUBMISSION OF THE TENDER IS 09.01.2014 up to 1.00PM - OPENING OF TENDER IS 09.01.2014 at 2.30PM

Director (Medical) Delhi ESI Corporation Page 15 of 29

ANNEXURE-“A” List of items

S. No. Name of the Items BIFILAC SACHET(0.5GM CONT:STREPTPCOCCUS FAECALIS 30 MIL.,CLOSTRIDIUM 1 BUTYRICUM 2MIL.,BACILLUS MESENTERICUS 1 MIL.,LACTIC ACID BAC.50MIL) C-1BILLION C.F.U OF LACTOBACILLUS RHAMNOSUS GR-1, LACTO.REUTERI RC-14 2 (ECOFLORA) 3 C-ANTIOXIDANT (ANTOXYL FORTE FORMULA) C-BIFILAC(PRE & PROBIOTIC)STREPTOCOCCUS FAECALIS 30MIL, CLOSTRIDIUM 4 BUTYRICUM 2MIL, BACILUS MESENTERICUS 1MIL, LACTIC ACID BACILUS SPOR. 50MIL) 5 C-CEFACLOR 500MG (DISTACLOR) 6 C-CYCLOSERIN 250 (MYSEP) 7 C-DEXTROPROPOXEPHEN 65MG + ACETAMINOPHEN 400MG (PROXYVON) 8 C-ESSENTIAL L (FORMULA) 9 C-FENOVERINE 100MG(SPASMOPRIV) C-FERROUS FUMARATE 200MG+ CYANCOBNALAMIN 15MCG + FOLIC ACID 1.5MG 10 (HEMSYNERAL TD) 11 C-IMATINIB MESYLATE 100MG (GLIVEC 100MG) 12 C-INDINAVIR 400MG C-KARVOL PLUS (CAMPHOR 25MG, EUCALYPTOL 125MG, CHLOROTHYMOL 5MG, 13 MENTHOL 55MG, TERPINEOL 120MG) 14 C-LITHIUM CARBONATE-300MG 15 C-NATURAL MICRONISED PROGESTRONE 100MG (DUBAGEST) 16 C-RIFAMPICIN 600MG C-SPASMOPROXYVON FORMULA(DICYCLOMINEHCL 10MG + DEXTRO- 17 PROPOXYPHENE HCL 65MG + ACETAMINOPHEN 400MG 18 C-SUNITINIB MALATE 50MG (SUTENT) 19 C-TEMOZOLAMIDE 250(TEMODAL) 20 C-TETRACYCLIN 250MG 21 C-VITAZYME 22 C-ZIDOVUDINE 100MG D-ALEX + PAED. DROPS(PHENYLEPHRINE HCL. 2.5MG, CHLORPHENIRAMINE 23 MALEATE 2MG PER ML) 24 D-AZELASTINE 0.05% EYE DROPS (OCULAST) D-BETAMETHASONE SOD. PHOS. 0.1%, NEOMYCIN SULPHATE 0.5% W/V (BETNESOL-N) 25 EYE DROPS 26 D-BETOXALOL 0.5% EYE DROPS 27 D-CETRIZINE HCL 10MG/ML DROPS 28 D-CHLORAMPHENICOL 5%, BENZOCAINE 1% EAR DROPS (BIOMYCETIN) D-CHLORAMPHENICOL 5%, LIGNOCAINE 2%, BECLOMETHASONE DIP. 0.025% 29 CLOTRIMAZOLE 1% EAR DROPS (CIROBIOTIC/OTEK AC) Page 16 of 29

30 D-CLOTRIM. 1% + LIGNOCIANE 2% EAR DROPS (CANDID) D-COLIMEX FORMULA( 1ML CONT: DICYCLOMINE HCL 10MG+ ACTIVATED 31 DIMETHICONE 40MG) 32 D-CYCLOPENTOLATE 1% EYE DROPS 33 D-DORZOLAMIDE 2%+TIMOLOL 0.5% EYE DROPS (MISOPT) D-HEPATOGLOBINE DROPS (PEPTONISED IRON 117.67MG EQV. TO 20MG OF 34 ELEMENTAL IRON, PROTEIN AS PEPTONE 30MG, F.A. 200MCG, VIT.B12 4MCG, PALATABLE BASE QS. 35 D-NATAMYCIN 0.5% W/V EYE DROPS 36 D-PREDNISOLONE ACETATE 1% EYE DROPS 37 D-TIMOLOL 0.5% (GLUCOMOL EYE DROP) 38 D-TRAVOPROST 0.004% EYE DROPS (TOVAXO) 39 D-TROPICAMIDE 1% EYE DROPS D-WAX SOFTNER EAR DROPS (ANTIWAX) PARA DICHLOROBENZENE 2% W/V, 40 BENZOCAINE 2.7 W/V, CHLORBUTOL 5%, TERPENTINE OIL 15% W/V D-ZINCULA EYE DROPS(BORIC ACID 80%, SOD.CH. 0.85%, NAPHAZOLINE HCL 0.02%, 41 SULPHATE 0.10%, PHENYL ETHYL 0.50%) EACH SACHET 0.67GM= WATER SOLUBLE AZULENE(SOD. AZULENESULFONATE) JPC 42 2.01MG L-GLUTAMINE JPC 663.30MG 43 I-5 FLU-URACIL 250MG 44 I-ACECLOFENAC 150MG/ML 45 I-AMOXY.250MG & CLAVULANIC ACID 50MG 46 I-AMOXYCILLIN 500MG & CLAVULENIC ACID 100MG 47 I-ATRACURIUM BESYLATE 10MG/ML 48 I-ATROPINE SULPHATE 0.6MG/1ML 49 I-AVASTIN 100MG (BEVACIZUMAB) 50 I-BEPLEX FORTE(B. COMPLEX)2ML. AMP 51 I-BETAMETHASONE 4MG/ML 52 I-BLEOMYCIN 15MG 53 I-BUPIVACAINE HCL 0.25% 54 I-BUPIVACAINE HCL 0.5% (BUPIVACAINE HEAVY) VIAL 55 I-CAPD LOW CALCIUM 2.5% (2LTR.) 56 I-CAPD LOW CALCIUN 1.5% (2LTR.) 57 I-CARBOPROST 0.25MG/ML (PROSTODIN) 58 I-CEFOTAXIME 500MG + SULBACTAM 250MG 59 I-CHLORAMPHENICOL 1G 60 I-CISPLATINUM 10MG 61 I-CISPLATINUM 50MG 62 I-CLARITHROMYCIN 500MG 63 I-CYCLOPHOSPHAMIDE 200MG 64 I-CYTOSINE ARABINOSIDE 100MG 65 I-DALTEPARIN SODIUM 2500IU (FRAGMIN 2500) 66 I-DALTEPARIN SODIUM 5000IU (FRAGMIN 5000) Page 17 of 29

67 I-DESOFERRAXAMINE 500MG (DESFERAL) 68 I- 5MG/ML 69 I-DICLOFENAC SOD. 25MG/ML(VOVERAN) 70 I-DICYCLOMINE 10MG/2ML 71 I-DOCETEXAL 80MG 72 I-ENOXAPRINE SOD. 20MG/0.2ML 73 I-EPIRUBICIN 10MG 74 I-EPIRUBICIN 50MG 75 I-EQUINE RABIES IMMUNOGLOBULIN 1500 76 I-ERYTHROPOETIN 2000 IU (RECOMBINANT HUMAN ERYTHROPOIETIN) 77 I-ERYTHROPOETIN 3000 IU (RECMBINANT HUMAN ERYTHROPOIETIN) 78 I-ETHAMSYLATE 125MG/ML 79 I-ETOPSIDE 100MG 80 I-GLYCOPYROLATE 0.2MG/ML 81 I- 5MG (SERENASE) 82 I-HEPATITIS B 10MCG PAED. (S.DOSE) 0.5ML 83 I-HEPATITIS B 20MCG (MULTI DOSE) 10ML 84 I-HEPATITIS -B 20MCG ADULT(S.DOSE) 1ML 85 I-HERCEPTIN 440MG (TRASTUZUMAB) 86 I-HUMAN CHORIONIC GONADOTROPIN 10000IU (PROFESSI) 87 I-HUMAN CHORIONIC GONADOTROPIN 2000 IU(PROFASSI) 88 I-HYDROXY PROGESTERONE 250MG (PROLUTON DEPOT-250MG) 89 I-HYDROXY PROGESTERONE 500MG (PROLUTON DEPOT) 90 I-HYLASE (HYALURONIDASE 1500UNITS) 91 I-IMIPENEM 500MG + CILASTATIN 500MG PER VIAL (CILANEM) 92 I-INSULIN GLARGINE 100UNITS/ML 93 I-INTERFERON ALPHA 2B 3MIL IU( INTALFA 3MIU) 94 I-IRON SORBITOL CITRIC ACID COMPLEX 50MG 95 I-LIGNOCAINE 2% (XYLOCAINE) 96 I-LIGNOCAINE 21.3MG WITH 0.005MG PER ML I-LIGNOCAINE 21.3MG,SODIUM CHLORIDE 6MG, WATER FOR INJECTION TO MAKE 97 1ML (XYLOCARD 2% IV) 98 I-LORNOXICAM 8MG PER 2ML VIAL 99 I-MAGNESIUM SULFATE 50% PER ML 100 I-MAINTENANCE SOLN. FOR PAED USE(ISOLYTE-P FORMULA) 101 I-MANNITOL 10% + GLYCERIN 10% INFUSION 102 I-MEPHENTERMINE (1 ML.) 103 I-MEPHENTERMINE 30MG/ML (10ML VIAL)(MEPHENTINE) 104 I-METHOTEXTRATE 50MG 105 I-METHOXY POLYTHENE GLYCOL EPOETIN-BETA 50MCG (MIRCERA) 106 I-METHYL PRED. SOD. SUCC. 125MG (SOLUMEDROL) 107 I-METHYL PRED. SOD. SUCC. 500MG (SOLUMEDROL) 108 I-METHYL PRED. SOD. SUCC.40MG(SOLUMEDROL) Page 18 of 29

109 I-METHYL PREDNISOLONE ACCETATE 40MG (DEPO-MEDROL) 110 I-METOPROLOL 1MG/ML 111 I-MIDAZOLAM 5MG (1ML) 112 I-MITOMYCIN 10MG 113 I-MITOMYCIN 2MG 114 I-NANDROLONE DECAONATE 25MG/ML (DECA DURABOLIN) 115 I-NANDROLONE PHENYL PROPIONATE 25MG (DURABOLIN) 116 I-NEOSTIGMINE(PROSTIGMINE) 0.5MG/ML 117 I-OFLOXACIN 100ML 118 I-PACLITAXEL 200MG 119 I-PACLITEXEL 30MG 120 I-PARNAPARIN 6400 (FLUXUM) 121 I-POTASSIUM CHLORIDE 0.15GM/ML 122 I- 25MG/ML(PHENERGAN) 123 I-RECOMBINANT FSH 75 (FOLICULIN 75) (MENOTROPIN INJ) 124 I-REVIPARIN SODIUM 0.6ML PFS 125 I-REVIPARINE SOD. 6ML MDV 126 I-RITUXIMAB 100MG(MEBTHERA) 127 I-RITUXIMAB 500MG(MEBTHERA) 128 I-SOD. CHLORIDE 0.9% (NORMAL SALINE) 129 I-SOMATROPIN (R-DNA ORIGIN) 18IU (HUMAN GROWTH HORMONE) 130 I-SOMATROPIN (R-DNA ORIGIN) 4IU (HUMAN GROWTH HORMONE) 131 I-SOMATROPIN 16 IU (R-DNA ORIGIN) (HUMAN GROWTH HARMONE) 132 I-TEICOPLANIN 400MG I-TISSEEL KIT(ANTI COAGULANT)(TWO COMPONENT FIBRIN SEALED WITH FAST 7 133 SLOW SETTING OF HUMAN THROMBIN) 134 I-TRANSXEMIC ACID 500MG/5ML (XAMIC) 135 I-VALETHAMATE 8MG/ML (EPIDOSIN) 136 I-VECURONIUM 4MG/AMP (NORCURON) 137 I-VINCRISTINE 1MG 138 I-VITAMIN K 1.0MG(0.5ML AMP) 139 L-CHLORHEXIDINE GLUCONATE SOLN 2.5%, ETHYL ALCOHOL 70%

140 L-CHOLINE SALICYLATE 9% W/V, BENZALKONIUM CHLORIDE 0.02% GEL (ZYTEE RB)

141 L-CLOTRIMAZOLE 1% IN PROPYLENE GLYCOL, GLYCERIN BASE (MOUTH PAINT) 142 L-CLOTRIMAZOLE 1% W/W+BECLOMETHASONE DIPROPIONATE 0.025% W/V BASE 143 L-CLOTRIMAZOLE 10MG/ML (CANDID) 144 L-COALTAR 4.25% + SALICYLIC ACID SOLN. 2% LOTION 145 L-GAMMA BENZENE HEXA CHLORIDE 1% LOTION 146 L-HYDROGEN PEROXIDE

147 L-LIDOCAINE 1%, CETRIMIDE 0.1%, POLYVINYL POLYMER 2.8% (LIDOCAINE SPRAY)

148 L-SURGICAL SPIRIT Page 19 of 29

149 L-TOPICAL LIGNOCAINE 4% (XYLOCAINE) 150 N-BECLOMETHASONE DIPROPIONATE 100MCG (BECLATE INHALER 100MCG) 151 N-BUDENOSIDE NASAL SPRAY 100MCG 152 N-FLUTICASONE 50MCG, SALMETEROL 25MCG INHALER (SERFLO 50 CFC FREE) 153 N-IPRATROPIUM 20MCG, LEVOSALBUTAMOL 50MCG INHALER (DUOLIN INHALER) 154 N-IPRATROPIUM 20MCG+SALBUTAMOL 100MCG( DUOLIN OF INHALER) 155 N-IPRATROPIUM BROMIDE 20MCG (IPRAVENT INHALER) 156 N-SALBUTAMOL 100MCG (ASTHALIN INHALER) N-SALBUTAMOL 100MCG + BECLOMETHASONE DIPROPIONATE 50MCG (AEROCORT 157 INHALER) 158 O-ACYCLOVIR 3% EYE OINT 159 O-ADAPALENE 0.1%+CLINDAMYCIN 1%W/W (ADACIN/DERIVA CMS) O-ANOVATE FORMULA(BECLOMETHASONE DIPROPIONATE 0.025%, 160 PHENYLEPHERINE HCL 0.1%, LIGNOCAINE HCL 2.5%) 161 O-ATROPINE SULPHATE 1% OINT. O-COTARYL CREAM (FORMULA: LACTIC ACID 6%, GLYCINE 3%, AMM.CL 162 0.5%,SOD.CL.0.5%, POT.CL. 0.5%, CAL LACTATE 0.5%, MAG.CL 0.3%, SOD.DIHYD.PHOS. 0.5% W/V 163 O-DINOPROSTONE 0.5MG (CERVIPRIME GEL) 164 O-FERACRYLUM 1% W/W GEL (SEPGARD) 165 O-FLUCINOLONE ACETONIDE 0.025% (FLUCORT) 166 O-FLUCREME NM (FORMULA) 167 O-FRAMYCETIN SKIN CREAM 30GM. 168 O-GBHC 1% BENZOCAINE 2% CREAM BASE (SCABOMA CREAM) 169 O-LIGNOCAINE OINTMENT-5% 170 O-LIGNOCIANE 2% JELLY (XYLOCAINE ) O-MELACARE FORTE(HYDROQUINONE 4%+TRETINOIN 0.025% + MOMETASONE 171 FUROATE 0.1%) O-NIMESULIDE 10MG, METHYL SALICYLATE 100MG, MENTHOL 50MG, CAPSCAICIN 172 0.25MG (NIZER GEL FORMULA) O-SALICYLIC ACID 6%, BENZOIC ACID 12%, HYDROCORTISONE ACETATE 0.5% W/W 173 (KERALIN OINT. FORMULA) 174 O-SALICYLIC ACID 6%, BETAMETHASONE 0.05% (20GM) 175 O-ZINC OXIDE OINT. 20GM TUBE 176 P-ADHESIVE TAPE 10CM X 5M HYPOALLERGENIC EXTRA POROUS 177 P-ADHESIVE TAPE 5CM X 5M HYPOALLERGENIC EXTRA POROUS 178 P-ADHESIVE TAPE 7.5CM X 5M HYPOALLERGENIC EXTRA POROUS P-PEGLEC (POLYETHYENE GLYCOL 118GM, POT.CL. 1.484GM, SOD.BICARBONATE 179 3.37GM, SOD.CH. 2.93, SOD.SULPHATE 11.36GM) P-ZINC BACITRACIN 400U, POLYUMYXIN B SULPHATE 5000U, NEOMYCIN SULPHATE 180 3400U 181 R-BECLOMETHASONE ROTACAPS 100MCG 182 R-FLUTICASONE 100MCG ROTACAPS Page 20 of 29

183 R-FLUTICASONE 250MG+ SALMETROL 50MCG (SEROFLO 250 ROTACAPS) 184 R-SALMETROL 50MCG ROTACAPS (SEROBID) 185 R-TIOTROPIUM BROMIDE 18MCG ROTACAPS (TIATE TRANSCAPS) 186 S-AMBROLITE S+(FORMULA) 187 S-AMOXYCILLIN 125MG + CLOXACILLIN 125MG (AMCLOX) 188 S-AMOXYCILLIN 200MG + CLAVULANIC ACID 28.5 MG (AUGMENTIN) 189 S-BECASULES SYP. (FORMULA) S-BROMHEXINE HCL 8MG, TERBUTALINE SULP. 4MG, GUAPHANESIN 190 200MG(ASMOTONE PLUS FORMULA) S-CLISTIN EXPECT.(CARBINOXAMINE MALEATE 4MG, AMMONIUM CHLORIDE 240MG, 191 SOD.CITRATE 240MG PER 10ML.) 192 S-CODEINE PHOSPHATE 10MG + CPM 4MG PER 5ML 193 S-CYCLOSPORIN 100MG/ML 194 S-DIGENE GEL/MAGLUGEL-F 195 S-DOMPERIDONE SUSPN.(1MG/ML) 196 S-ETOPHYLLINE 46.5MG + THEOPHYLLINE 14MG PER 5ML(DERIPHYLLIN) 197 S-GROVIT / VISYNERAL 200ML (FORMULA) S-HIPHYLATE (THEOPYLLIN ETHANOATE OF 80MG, EPH HCL 12MG, 198 GUAIPHENESIN 50MG, ALCOHOL 0.55ML, ABSL.ALCOHOL CONTENT 10.44%) 199 S-IBUPROFEN 100MG/5ML 200 S-LACTULOSE 100ML ( EACH 15ML : LACTULOSE 10GM) 201 S-LEXATIVE ENEMA(GLYCERIN 15%, SOD.CHLORIDE 15%) S- DISORDER SYP.(TRISOLIV) (TRICHOLINE CIT. 250MG, KALMEGH EQ.TO 202 ANDOGRAPHOLIDES 250MCG, SORBITOL SOLN.) 203 S-LORATADINE 5MG PER 5ML 204 S-MUCAINE GEL 205 S-NALIDIXIC ACID 300MG/5ML (WINTOMYLON) 206 S-NEUTROSEC FORMULA 207 SOD.AMINOSALICYLATE 800 (PAS GRANUL) 208 S-PHENIRAMINE MAL. 15MG/5ML (AVIL) 209 S-PIPERZINE CIT. EQV TO 0.75GM OF PIPERZINE HYDRATE PER 5ML S-RELCER GEL FORMULA (5ML CONT:AL.HYD.6G+MG.HYD.80MG+ACTIVATED 210 DIMETHICONE 100MG+DEGLYCYCRRHIZINATED LIQUORACE EQV.TO LIQUORICE 400MG 211 S-SALBUTAMOL 2MG/5ML 212 S-SODIUM VALPROATE 200MG/5ML 213 S-TERBUTALINE SUPLHATE 1.5MG/5ML 214 S-TRICLOFOS SOD.500MG/5ML(KHUSHI) S-VOLINI SPRAY (DICLO.DIETHYLMINE 1.16%, METHYL SALICYLATE 10%, LINSEED 215 OIL 3%, MENTHOL 5%, EXCIPIETS & PROPELLANT Q.S.100%) 216 T-ACENOCOUMAROL 1MG (ACITROM) 217 T-ALENDRONATE 35MG(OSTEOFOS) 218 T-ALENDRONATE 70MG(OSTEOFOS) Page 21 of 29

219 T-AMIODARONE 200MG(CARDRONE) 220 T- 25MG 221 T-AMOXYCILLIN 200MG+CLAVULANIC ACID 28.5MG DISP. 222 T-AMOXYCILLIN 250MG + CLAVULANIC ACID 125MG (AUGMENTIN 375) 223 T-AMOXYCILLIN 500MG + CLAYULANIC ACID 125MG (AUGMENTIN 625) 224 T-ANASTROZOLE (ARIMIDEX) 1MG 225 T-ARCOLVIT (NEUTROSEC FORMULA) 226 T-ARTESUNATE 50MG 227 T-ATORVASTATIN 10MG 228 T-AZATHIOPRINE 50MG 229 T-BISOPROLOL FUMERATE 5MG T-CAL. CARB. 1250MG EQV TO ELEMENTAL CAL. 500MG + VIT D3 250IU (SHELCAL 230 500MG FORMULA) T-CALCIUM CITRATE EQV TO ELEMENTAL CALCIUM 200MG, ZINC SULP. 4MG, 231 MONOHYDRATE MAGNESIUM HYDROXIDE 50MG, VIT D3 200IU (MILICAL XP) 232 T-CAPECITABINE 500MG (XELODA) 233 T- 400MG CR 234 T-CARBIMAZOLE 5MG (NEOMERCAZOLE) 235 T-CARVEDILOL 12.5MG 236 T-CARVEDILOL 3.125MG 237 T-CARVEDILOL 6.25MG 238 T-CEFIXIME 200MG+LACTIC ACID 60MIL. 239 T-CEFUROXIME 250MG (CEFTUM) 240 T-CEFUROXIME 500MG 241 T-CINNARIZINE 25MG (STUGERON ) 242 T-CLOBAZAM 10MG (FRISIUM) 243 T-CLOBAZAM 5MG(FRISIUM) 244 T-CLONAZEPAM 0.5MG(RIVOTRIL) 245 T-CLONAZEPAM 1MG 246 T-CONJUGATED OESTROGEN 0.625(PREMARIN) T-DAFLON 500MG (MICRONISED PURIFIED FRACTION OF RUTACEAE 247 500MG) 248 T-DEFERASIROX 100MG (ASUNRA) 249 T-DEFERASIROX 400MG (ASUNRA) 250 T-DIDROGESTRONE 10MG(DUPHASTON) 251 T-DIGOXIN 0.25MG 252 T-DILTIAZEM 120MG SR 253 T-DILTIAZEM SR 90MG T-DIOVOL FORMULA (DR. AL. HUD. GEL 240MG+MG. HY. 100MG+MAG.CARBONATE 254 60MG+ACTIVATED DIMETHICONE 25MG 255 T-DROTAVERINE 80MG 256 T-EBASTINE 20MG(EBAST) 257 T-ECOSPORIN 325MG (ACETYL SALICYLIC ACID 325MG) Page 22 of 29

258 T-ENALAPRIL MALEATE 2.5MG 259 T-ESCITALOPRAM 10MG 260 T-ESCITALOPRAM 20MG 261 T-ETHAMSYLATE 250MG 262 T-ETHAMSYLATE 500MG 263 T-ETHIONAMIDE 250MG 264 T-ETOPHYLLIN 77MG +THEOPHYLLIN 23MG(DERIPHYLLINE PLAIN) 265 T-FAMOTIDINE-40MG T-FERROUS CALCIUM CITRATE 278MG EQV TO 25MG IRON, 36MG CALCIUM, 0.3MG 266 FOLIC ACID 267 T- 250MG 268 T-GABAPENTINE 300MG 269 T-GABAPENTINE 400MG 270 T-GAFTINET 250MG 271 T-GLICLAZIDE MR 60MG (DIAMICRON) 272 T-GLYBENCLAMIDE-5MG(BETANASE) 273 T-HALOPERIDOL 1.5MG 274 T-HALOPERIDOL 5MG 275 T-HYDROXY UREA 500MG 276 T- HCL 25MG(ATAREX) 277 T-ISOSORBIDE MONONITRATE 30MG SR (IMDURE 30MG SR) 278 T-ISOSORBIDE MONONITRATE 60MG SR (IMDURE 60MG SR) 279 T-ITRACANAZOLE 100MG 280 T-IVABRADINE 5MG(CORALAN) 281 T-LAPATINIB 250MG(TYKERB) 282 T-LETROZOLE 2.5MG 283 T-LEVAMISOLE-150MG(DECARIS) 284 T-LEVONORGESTREL 75MG 285 T-LOSARTAN 25MG 286 T-LOSARTAN 50MG 287 T-LOSARTAN 50MG+ HYDROCHLORTHIAZIDE 12.5MG 288 T-MECLIZINE HCL 25MG + CAFFEINE 20MG (PREGNIDOXIN) 289 T-MEFTAL SPAS(DICYCLOMINE 10MG, MEFANAMIC ACID 250MG) 290 T-MESACOL (MESALAZINE 5-AMINOSALICYLIC ACID-400MG) 291 T-MESTEROLONE 25(PROVIRONUM) 292 T-METADOXINE 500MG(METADOXIL) 293 T-METAPROLOL TARTRATE 50MG 294 T-METHOTREXATE 2.5MG 295 T-METHYL PREDNISOLONE 16MG (MEDROL) 296 T-METOLAZONE 5MG 297 T-MIFEPRISTONE 200MG 298 T-MYCOPHENOLATE MOFETIL 500 (CELLCEPT) 299 T-NICORANDIL 10MG (NIKORAN) Page 23 of 29

300 T-NIFEDIPINE SR 20MG (DEPIN RETARD) 301 T-NITRAZEPAM-5MG(NITRAVIT) 302 T- 2.5MG 303 T- 4MG(EMESET ) 304 T-ORNIDAZOLE 500MG 305 T-PAROXETINE 10MG 306 T-PAROXETINE 20MG 307 T-PERINDOPRIL 2MG (COVERSYL) 308 T-PERINDOPRIL 4MG (COVERSYL) 309 T-PERINDROPIL 4MG + AMLODIPINE 5MG (COVERSYL AM) 310 T-POVIDONE VAGINAL 200MG (BETADINE VAGINAL) 311 T-PREDNISOLONE 10MG 312 T--5MG(STEMETIL) 313 T-PYRAZINAMIDE 1000MG 314 T- HCL 100MG(B-LONG) 315 T-RABEPRAZOLE 20MG 316 T-RESPERIDONE 1MG 317 T-SECNIDAZOLE 1GM 318 T-SERTRALINE 50MG 319 T-SEVELAMER 400MG(SEVAGEL) 320 T-SOD.VALPORATE-200MG 321 T-TELMISARTAN 40MG 322 T-TERAZOCIN 2MG 323 T-TERBUTALINE SULPHATE 5MG 324 T-THEOPHYLLIN CR 200MG 325 T- 4MG +DICLOFENAC SODIUM 50MG 326 T-THYROXINE SODIUM 50MCG 327 T-TIANEPTINE SOD.12.5MG(STABLON) 328 T-TIZANIDINE 2MG(SIRDALUD) 329 T-TOLPERISONE HCL JPC 450MG 330 T-TRIAMTERINE 50MG + BENZTHIAZIDE 25MG (DITIDE) 331 T-TRIHEXYPHENIDYL 2MG (PACITANE) 332 T-TRYPSIN CHYMOTRYPSIN 1 LAC UNITS (CHYMORAL FORTE) 333 T-VALSARTAN 80MG (VALZAAR 80) 334 T- 10MG 335 T-ZOLPIDEM 5MG(NITREST) 336 T-DOXYFYLLINE 400MG 337 N-LEVOSALBUTAMOL TART.50MCG INHALER 338 T-NEBIVOLOL 2.5MG (NEBICARD) 339 T-NEBIVOLOL 5MG (NEBICARD) 340 T-TELMISARTAN 40MG, AMLODIPINE 5MG 341 T-INDAPAMIDE SR 1.5MG, AMLODIPINE 5MG 342 T-ETORICOXIB 90MG Page 24 of 29

343 C-DICLOFENAC COLESTYRAMINE 145.6MG (DICLOFENAC RESINATE) 344 C- 200MG(CLOTAN) 345 T-ZOLPIDEM TART.6.25MG(STILNOCT) 346 T-LITHIUM CARBONATE 150MG 347 T-SERTRALINE 25MG 348 T-TAMSULOSINE 0.4MG (URIMAX) 349 T-TIBOLONE 2.5MG(LIVIAL) 350 T-ETHINYLESTRADIOL 0.02 + DESOGESTREL 0.15MG 351 T-DESOGESTREL 75MCG(LOW DOSE PROGESTRONE ORAL PILL)(CERAZETTE) 352 T-BETAMETHASONE 1MG 353 T-GLIPIZIDE 5MG (GLYNASE) 354 T-VOGLIBOSE 0.2MG 355 T-SITAGLIPTINE 50+METFORMIN 500MG (JANUMET) 356 T-SITAGLIPTINE 50 + METFORMINE 1000MG (JANUMET) 357 T-VILDAGLIPTINE 50 + METFORMIN 500MG 358 T-VILDAGLIPTIN 50 + METFORMIN 1000MG 359 T-CLINDAMYCIN 300MG 360 T-SEBIVO 600MG (TELBIVUDINE) 361 T-DAPSONE-100MG 362 C-EVION-400MG( VITAMIN E 400MG)

T-BEPLEX FORTE (THIAMINE MONONITRATE 10MG, RIBOFLAVIN 10MG, NICOTINIC 363 ACID 25MG, NIACINAMIDE 75MG, PYRIDOXIN HCL. 3MG, CAL. PENTOTHENATE 50MG, FOLIC ACID 1.5MG, VIT.B-12 15MCG, VIT.C 150MG, BIOTIN 260MCG, LIGHT MAGNESIUM OXIDE EQV. TO ELEMENTAL MAGNESIUM 32.4MG)

T-CALCIUM & MINERALS (CALCIUM CARBONATE 1000MG FROM ORGANIC SOURCE (OYSTER SHELL) EQV. TO ELEMENTAL CALCIUM 400MG, HEAVY MAGNESIUM OXIDE 364 150MG EQV. TO ELEMENTAL MAGNESIUM 90MG, ZINC SULPHATE MONOHYDRATE 13.75MG EQV. TO ELEMENTAL ZINC 5MG, L- HCL 100MG, PYRIDOXINE HCL 1.5MG, CHOLECALCIFEROL 200IU) C-TRIPLE A CAL OS (ELEMENTAL CALCIUM 150MG IN THE FORM OF CAL. HYDOXIDE 365 & CAL. OXIDE PRETREATED WITH HEATED ALGAE, ZINC SULPHATE MONOHYDRATE EQV. TO ELEMENTAL ZINC 7.5MG, CALCITRIOL 0.25MCG.) 366 C-IMATINIB 400MG 367 T-TACROLIMUS 1MG 368 T-ERLOTINIB 100(TARCEVA) 369 C-NILOTINIB 200(TASIGNA) 370 I-DICYCLOMINE 20MG, DICLOFENAC SODIUM 50MG 371 O-PROTOCREAM 20GM TUBE 372 I-OMALIZUMAB 150MG(XOLAIR) 373 N-BUDESONIDE 1MG RESP. SOLN.2ML. 374 I-DILTIAZEM 375 I-FACTOR VIII BYPASSING ACTIVITY, ANTI INHIBITOR-COAGULANT COMPLEX 500IU Page 25 of 29

376 I-RECOMBINANT HEMOPHILLIC FACTOR VIII 250 IU 377 I-RECOMBINANT HEMOPHILLIC FACTOR VIII 500 IU 378 I-RECOMBINANT HEMOPHILLIC FACTOR VIII 1000 IU 379 I-SYNVISC ONE (HYLAN G-F20) 380 I-ACTEMRA 80MG (TOCILIZUMAB) 381 I-ACTEMARA 200MG (TOCILIZUMAB) 382 I-ACTEMRA 400MG (TOCILIZUMAB) 383 I-HUMAN INSULIN (50%SOL+50%NPH) 384 I-INSULIN LISPRO 100IU/ML (HUMALOG) 385 I-CLINDAMYCIN 600MG 386 I-TIGECYCLINE 50MG(TEVRAN) 387 I-TOBRAMYCIN 20MG 388 I-TOBRAMYCIN 60MG 389 I-TOBRAMYCIN 80MG 390 I-AMPHOTERICIN B 50MG 391 I-ACYCLOVIR 500MG/VIAL 392 O-CHLORAMPHENICOL 1% INPLIABLE GELATIN CAPS. WITH ELONGATED TIP EYE APPLICAP 393 D-BETAMETHASONE SOD. PHOS. 1% EYE DROPS 394 D-HOMATROPINE HYDROBROMIDE 2% EYE DROPS 395 D-DEXAMETHASONE SOD. PHOSPHATE 0.1%, NEOMYCIN SULPHATE 0.5%, BENZALKONIUM CHLORIDE IN ISOTONIC SOLN. 0.02% EYE DROPS D-MOISOL EYE DROPS (HYDROXYPROPYL METHYL CELLULOSE 0.7%, BORAX 0.19%, 396 BORIC ACID 0.19%, SOD. CHLORIDE 0.45%, POT. CHLORIDE 0.37%, BENZALKONIUM CHLORIDE 0.01%) 397 O- 0.3% W/W EYE OINT. 398 D-OFLOXACIN 0.3%,PRED.ACETATE 1% 399 I-LUCENTIS (RANIBIZUMAB 10MG) 400 D-NEOSPORIN H EAR DROPS (POLYMYXIN B SULPHATE 10000IU, NEOMYCIN SULPHATE 3400IU, HYDROCORTISONE 10MG W/W) 401 N-BECLATE NASAL SPRAY (BECLOMETHASONE DIPROPIONATE 50MCG) 402 N-AZELASTINE 0.05% NASAL SPRAY 403 O-TRIAMCINOLONE ACETONIDE 0.1 OINT. 404 O-AZELAIC ACID 10% CREAM (AZIDERM) 405 I-ROCURONIUM 50MG 406 I-VITAMIN D3 3LAC IU PER AMP. 407 I-HAEMO DIALASIS FLUID(AT-CITRATE 408 I-FRUCTODEX WATER(INVERT SUGER 10G. 409 I-FRUCTODEX SALINE 410 I-BORTEZOMIB 1MG(VELCADE) 411 I-BORTEZOMIB 3.5MG(VELCADE) 412 I-CABAZITAXEL 60MG(JEVTANA) 413 I-HEPATITIS B IMMUNOGLOBULIN 100IU Page 26 of 29

414 S-SUCRALFATE100,OXETACAINE 20MG /10ML

P-PRE & PROBIOTIC & ORAL REHYDRATION (BIORS SACHET) WHO ORS PACK 4.10G. CONTAINS: SOD.CHLORIDE 0.52G, SOD. CIRATE 0.58G, POT.CHLORIDE 0.3G, DEXTROSE ANHYDROUS 2.7G & PRE & 415 PROBIOTIC PACK 0.5G CONTAINS: STREPTOCOCCUS FAECALIS T-110 7.5MILLION, CLOSTRIDIUM BUTYRICUM TO-A 0.5MILLION, BACILLUS MESENTERICUS TO-A 0.25 MILLION, LACTOBACILLUS SPOROGENES 20 MILLION) 416 S-AMBRODRY 417 S-DIGOXIN SYP. 418 S-ENTECAVIR 0.05MG PER ML (BARACLUDE) 419 S-RIFAMPICIN-100MG/5ML 420 L-MOMETASONE FUROATE 0.1% LOTION (MOMATE) 421 B-PAPER ADH. TAPE 2.5CMX9.14M 422 B-PAPER ADH. TAPE 5CMX9.14M 423 B-FERACRYLUM 3% DRESSING(SEPGARD TULLE COTTON) 424 S-HEPATOGLOBINE MIKROS (PEPTONISED IRON 176.5MG EQV. TO 30MG OF ELEMENTAL IRON, PROTEIN AS PEPTONE 100MG, FA 200MCG, VITAMIN B12 2.5MCG)

Page 27 of 29

ANNEXURE-B

PRE-RECEIPT

Received Rs______(Rupees______)towards refund of

Earnest money vide Challan No______Dated______in respect of tender for Testing of Drug dated______.

(Signature of the bidder with stamp)

Page 28 of 29

Annexure “c”

MANDATE FORM BENEFICIARY’S OPTION TO RECEIVE PAYMENT THROUGH e-PAYMENT 1. BENEFICIARY NAME 2. BENEFICIARY ADDRESS 3. BENEFICIARY ACCOUNT NO. 4. ACCOUNT TYPE (S.B. ACCOUNT/CURRENT ACCOUNT FOR CASH CREDIT) WITH CODE 10/11/13 5. 9 DIGIT CODE NUMBER OF THE BANK & BRANCH APPEARING ON THE MICR CHEQUE ISSUED BY 6. BANK NAME 7. BANK NAME ADDRESS TELEPHONE NO. 8. IFSC (INDIAN FIANANCIAL SERVICE CODE) 9. PHOTOCOPY OF CANCELLED CHEQUE TO CONFIRM CORRECTNESS OF IFSC CODE AND ACCOUNT NO. GIVEN IN C & H

I, HEREBY, DECLARE THAT THE PARTICULARS GIVEN ABOVE ARE CORRECT AND COMPLETE. IF THE TRANSACTION IS DELAYED OR NOT EFFECTED AT ALL FOR REASON OF INCOMPLETLE ON INCORRECT INFORMATION GIVEN BY ME AS ABOVE, I WOULD NOT HOLD THE USER INSTITUTION RESPONSIBLE.

DATED ______(______) SIGNATURE OF THE BENEFICIARY/CUSTOMER

CERTIFIED THAT THE PARTICULATES FURNISHED ABOVE ARE CORRECT AS PER OUR RECORDS.

BANK’S STAMP

DATE ______(______) SIGNATURE OF THE AUTHORISED/OFFICIAL

Page 29 of 29

Annexure-V

Date ______

UNDERTAKING

I/WE undersigned is /are authorized signatory/signatories of the firm M/s ______Address ______do here by undertake that

1. The firm is in this business in continuation from Year 2010 .

2. If any information in the tender submitted by me is found incorrect/false at any time Tender is liable to be rejected.

Authorized signatory

(With rubber stamp)